Annual EBIT
$5.30B$3.15B-37.28%
Summary
- Current Value
- As of today, GSK annual EBIT is $5.30B, down -37.28% on
- Historical Performance
- GSK annual EBIT is down -11.72% over the past 3 years, and down -41.55% over the past 5 years
- All-Time High Comparison
- GSK annual EBIT is currently -69.21% below its historical high of $17.21B set on
- 3-Year Low Comparison
- GSK annual EBIT is at its 3-year low
- Sector Comparison
- GSK annual EBIT is higher than 98.48% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | $5.30B | -37.3% | -11.7% | -41.5% | -61.0% | |
| Quarterly EBIT | $3.47B | +460.2% | +40.0% | +17.3% | +19.3% | |
| TTM EBIT | $9.88B | +36.3% | +26.7% | +9.0% | +6.7% | |
| Price | $50.22 | +48.8% | +43.8% | +28.5% | +27.1% | |
| PE Ratio | 14.32 | -32.9% | +260.7% | +33.2% | -55.0% | |
| Annual Revenue | $40.09B | +6.3% | +18.0% | -6.9% | -9.9% | |
| Annual EPS | $1.59 | -46.7% | -57.3% | -46.2% | -62.6% | |
| Annual EBITDA | $9.11B | -19.4% | +2.1% | -24.3% | -43.2% | |
| Annual Net Income | $3.77B | -42.9% | -22.0% | -43.9% | -57.6% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $8.45B | -37.3% | |
| 5Y | $8.45B | -37.3% | |
| All | $17.21B | -69.2% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $5.30B | at low | |
| 5Y | $5.30B | at low | |
| All | $0.00 | N/A |
EBIT History
FAQ
What is the current annual EBIT of GSK?
As of today, GSK annual EBIT is $5.30B
What is 1-year change in GSK annual EBIT?
GSK annual EBIT is down -37.28% year-over-year
What is 3-year change in GSK annual EBIT?
GSK annual EBIT is down -11.72% over the past 3 years
How far is GSK annual EBIT from its all-time high?
GSK annual EBIT is currently -69.21% below its historical high of $17.21B set on December 31, 2015
How does GSK annual EBIT rank versus sector peers?
GSK annual EBIT is higher than 98.48% of companies in Healthcare sector
When is GSK next annual earnings release?
The next annual earnings release for GSK is on
Quarterly EBIT
$3.47B$1.18B+51.41%
Summary
- Current Value
- As of today, GSK quarterly EBIT is $3.47B, up +51.41% on
- Historical Performance
- GSK quarterly EBIT is up +460.19% year-over-year, and up +40.01% over the past 3 years
- All-Time High Comparison
- GSK quarterly EBIT is currently -12.60% below its historical high of $3.97B set on
- 3-Year Low Comparison
- GSK quarterly EBIT is +460.19% above its 3-year low of $618.81M reached on
- Sector Comparison
- GSK quarterly EBIT is higher than 99.20% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | $3.47B | +51.4% | +460.2% | +40.0% | +17.3% | |
| Annual EBIT | $5.30B | – | -37.3% | -11.7% | -41.5% | |
| TTM EBIT | $9.88B | +40.5% | +36.3% | +26.7% | +9.0% | |
| Price | $50.22 | +15.8% | +48.8% | +43.8% | +28.5% | |
| PE Ratio | 14.32 | +15.9% | -32.9% | +260.7% | +33.2% | |
| Quarterly Revenue | $11.52B | +8.0% | +10.6% | +25.2% | +3.2% | |
| Quarterly EPS | $1.32 | +41.1% | +3676.5% | -78.7% | +66.0% | |
| Quarterly EBITDA | $4.46B | +16.3% | +140.5% | +10.3% | +17.9% | |
| Quarterly Net Income | $2.89B | +31.5% | +3321.0% | +215.7% | +56.5% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.47B | at high | |
| 3Y | $3.47B | at high | |
| 5Y | $3.47B | at high | |
| All | $3.97B | -12.6% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.43B | N/A | +142.2% |
| 3Y | $618.81M | +460.2% | |
| 5Y | $618.81M | +460.2% | |
| All | -$5.59B | +162.0% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of GSK?
As of today, GSK quarterly EBIT is $3.47B
What is GSK quarterly EBIT most recent change?
GSK quarterly EBIT was up +51.41% on September 1, 2025
What is 1-year change in GSK quarterly EBIT?
GSK quarterly EBIT is up +460.19% year-over-year
How far is GSK quarterly EBIT from its all-time high?
GSK quarterly EBIT is currently -12.60% below its historical high of $3.97B set on December 31, 2000
How does GSK quarterly EBIT rank versus sector peers?
GSK quarterly EBIT is higher than 99.20% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM EBIT
$9.88B$2.85B+40.49%
Summary
- Current Value
- As of today, GSK TTM EBIT is $9.88B, up +40.49% on
- Historical Performance
- GSK TTM EBIT is up +36.26% year-over-year, and up +26.74% over the past 3 years
- All-Time High Comparison
- GSK TTM EBIT is currently -34.10% below its historical high of $14.99B set on
- 3-Year Low Comparison
- GSK TTM EBIT is +40.49% above its 3-year low of $7.03B reached on
- Sector Comparison
- GSK TTM EBIT is higher than 98.84% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | $9.88B | +40.5% | +36.3% | +26.7% | +9.0% | |
| Annual EBIT | $5.30B | – | -37.3% | -11.7% | -41.5% | |
| Quarterly EBIT | $3.47B | +51.4% | +460.2% | +40.0% | +17.3% | |
| Price | $50.22 | +15.8% | +48.8% | +43.8% | +28.5% | |
| PE Ratio | 14.32 | +15.9% | -32.9% | +260.7% | +33.2% | |
| TTM Revenue | $42.06B | +2.7% | +6.0% | +13.4% | -3.7% | |
| TTM EPS | $3.51 | +63.4% | +128.1% | -59.0% | -12.9% | |
| TTM EBITDA | $14.54B | +21.8% | +27.0% | +30.7% | +55.7% | |
| TTM Net Income | $7.96B | +54.4% | +121.5% | +66.2% | -11.3% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $9.88B | at high | |
| 3Y | $9.88B | at high | |
| 5Y | $9.88B | at high | |
| All | $14.99B | -34.1% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $7.03B | +40.5% | |
| 3Y | $7.03B | +40.5% | |
| 5Y | $7.03B | +40.5% | |
| All | -$41.95M | >+9999.0% |
TTM EBIT History
FAQ
What is the current TTM EBIT of GSK?
As of today, GSK TTM EBIT is $9.88B
What is GSK TTM EBIT most recent change?
GSK TTM EBIT was up +40.49% on September 1, 2025
What is 1-year change in GSK TTM EBIT?
GSK TTM EBIT is up +36.26% year-over-year
How far is GSK TTM EBIT from its all-time high?
GSK TTM EBIT is currently -34.10% below its historical high of $14.99B set on June 30, 2008
How does GSK TTM EBIT rank versus sector peers?
GSK TTM EBIT is higher than 98.84% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
EBIT Formula
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1131399/000113139925000007/0001131399-25-000007-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk